Cancer chemotherapy resistance: Mechanisms and recent breakthrough in targeted drug delivery

F Davodabadi, SF Sajjadi, M Sarhadi… - European Journal of …, 2023 - Elsevier
Conventional chemotherapy, one of the most widely used cancer treatment methods, has
serious side effects, and usually results in cancer treatment failure. Drug resistance is one of …

Research trends on nanomaterials in gastric cancer: a bibliometric analysis from 2004 to 2023

LX Ling, Y Ouyang, Y Hu - Journal of Nanobiotechnology, 2023 - Springer
Background Gastric cancer is one of the leading causes of cancer-related deaths worldwide.
In recent years, an increasing number of studies aimed at designing and develo** …

Vaccines in breast cancer: challenges and breakthroughs

GN Fatima, H Fatma, SK Saraf - Diagnostics, 2023 - mdpi.com
Breast cancer is a problem for women's health globally. Early detection techniques come in
a variety of forms ranging from local to systemic and from non-invasive to invasive. The …

Targeted therapies against breast cancer: Clinical perspectives, obstacles and new opportunities

D Nagpal, R Verma, V Mittal, P Jeandet… - Journal of Drug Delivery …, 2023 - Elsevier
Breast cancer is a multifaceted, heterogeneous disease that manifests in the mammary
gland. According to the WHO, more than 2.3 million cases are diagnosed each year, making …

Immunotherapeutic approaches in ovarian cancer

H Yoon, A Kim, H Jang - Current Issues in Molecular Biology, 2023 - mdpi.com
Ovarian cancer (OC) is gynecological cancer, and diagnosis and treatment are continuously
advancing. Next-generation sequencing (NGS)-based diagnoses have emerged as novel …

Dendritic cells in cancer immunology and immunotherapy

L Hato, A Vizcay, I Eguren, JL Pérez-Gracia… - Cancers, 2024 - mdpi.com
Simple Summary Although immune check point inhibitors have been established as a new
paradigm in cancer treatment, they have shown no clinical benefit in immune excluded or …

Cyclic RGD-functionalized pH/ROS dual-responsive nanoparticle for targeted breast cancer therapy

P Yao, X Wang, Q Wang, Q Dai, Y Peng, Q Yuan… - Pharmaceutics, 2023 - mdpi.com
Breast cancer is the most common malignant tumor in women and is a big challenge to
clinical treatment due to the high morbidity and mortality. The pH/ROS dual-responsive …

Exploring contemporary breakthroughs in utilizing vesicular nanocarriers for breast cancer therapy

NU Kumari, E Pardhi, PS Chary, NK Mehra - Therapeutic Delivery, 2024 - Taylor & Francis
Breast cancer (BC) is a heterogeneous disease with various morphological features,
clinicopathological conditions and responses to different therapeutic options, which is …

The potential role and mechanism of circRNAs in Ferroptosis: A comprehensive review

J Arabpour, K Rezaei, JY Kho**i, S Razi… - … -Research and Practice, 2024 - Elsevier
Cell death encompasses various mechanisms, including necrosis and apoptosis.
Ferroptosis, a unique form of regulated cell death, emerged as a non-apoptotic process …

Defining the emergence of new immunotherapy approaches in breast cancer: role of myeloid-derived suppressor cells

ML Sánchez-León, C Jiménez-Cortegana… - International Journal of …, 2023 - mdpi.com
Breast cancer (BC) continues to be the most diagnosed tumor in women and a very
heterogeneous disease both inter-and intratumoral, mainly given by the variety of molecular …